On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayFeb 09, 2022 10:00 am

The New England Cannabis Convention To Be Held In Boston

Cannabis growers, traders, industry professionals, and enthusiasts are invited to attend the New England Cannabis Convention (“NECANN”), on March 18-20, 2022. NECANN events, organized since 2014 are considered as one of the largest cannabis events on the east coast. The NECANN events attract a huge number of Hemp, MMJ and Cannabis traders/professionals in the Northeast in the annual Boston Cannabis Convention. These events are the home base for the New England cannabis industry.  The New England Cannabis Convention in Boston offers a viable avenue for learning the intricacies of the Cannabis Industry and establishing networking and communication among cannabis growers,…

Continue Reading

WednesdayFeb 09, 2022 9:45 am

American Cannabis Partners Committed to Sustainable Business Practices

Top companies recognize the “massive opportunity of sustainability” Consumers are becoming increasingly aware and supportive of companies working to make a difference ACP follows an organic cultivation model that includes the implementation of sustainable operating practices Sustainability is a growing concern — and priority — for businesses in today’s environment-conscious and energy-aware world, and smart companies, including American Cannabis Partners (“ACP”), are committed to doing their part. A multistate cannabis company, ACP is committed to operating its business with a positive impact on the environment, employees and customer experience. “Companies at the top of their industries recognize the massive opportunity of sustainability…

Continue Reading

WednesdayFeb 09, 2022 9:30 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Files Audited FY 2021 Financial Statements; On Track to Commercialize its Green Ammonia Production System

FuelPositive just filed its audited financial statements for the year ended September 30, 2021 Initial demonstration systems for green ammonia production are scheduled for launch and validation, starting in mid-2022 FuelPositive has also hired Counsel Public Affairs Inc. to offer government relations services It also announced the appointment of Jeanne Milne to lead the company’s efforts to secure government grants The company’s new head office will be located within the Kitchener-Waterloo area, and new staff will be joining the company once the space is secured FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) just filed its audited financial statements for the 2021 financial…

Continue Reading

WednesdayFeb 09, 2022 9:15 am

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Win Judicial Stay of the FDA’s Marketing Denial Order

Kaival Brands is the exclusive global distributor of products manufactured by Bidi Vapor LLC Bidi Vapor announced that it has been granted a judicial stay of the marketing denial order issued by the FCA in September 2021, which will permit the company to market all its products in the United States, pending the outcome of the lawsuit Kaival Brands expect the decision to result in a significant rebound in BIDI(R) Stick sales, with the company’s distribution partners expected to reestablish previous sales volumes Kaival Brands Innovations Group (NASDAQ: KAVL), the exclusive global distributor of products manufactured by Bidi Vapor LLC…

Continue Reading

WednesdayFeb 09, 2022 9:00 am

Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate

The blood glucose monitoring system sector is expected to grow to a value of $27.2 billion by 2026, expanding at a CAGR of 9.6% between 2021-2026 Over 420 million people around the globe currently have diabetes, with the American Diabetes Association recommending that all adults screen for the condition every three years Nemaura Medical has sought to capitalize on the blood glucose monitoring sector’s phenomenal growth rate through the launch of its proprietary body worn continuous glucose sensor in both the diabetes sector and consumer healthcare sector. The company’s flagship sugarBEAT(R) device provides diabetic and pre-diabetic patients with the ability…

Continue Reading

WednesdayFeb 09, 2022 9:00 am

Impending Merger Between Growth Capital Acquisition Corp. (NASDAQ: GCAC) and Cepton Technologies, Inc. Approaches; Shareholder Special Meeting on February 9, 2022

GCAC announces another milestone that brings company closer to completing impending transaction with Cepton Technologies, a Silicon Valley developer of LiDAR-based innovative technology SEC declared effectiveness of Registration Statement and Special Meeting date for proposed business combination where stockholders will vote to approve transaction Cepton provides highly competitive price-for-performance LiDARs; initially targets advanced driver assistance systems (“ADAS”) segment but is poised to expand into new markets and applications Growth Capital Acquisition (NASDAQ: GCAC), a special purpose acquisition company, announced that it would hold the Special Meeting of its stockholders at 10:00 A.M. Eastern Time on February 9, 2022, following the…

Continue Reading

TuesdayFeb 08, 2022 1:27 pm

Kronos Advanced Technologies Inc. (KNOS) Is ‘One to Watch’

Kronos’ planned West Virginia factory improvements are on schedule, expected to finish in Q1 2022 The company is currently developing new consumer electronics products in the wellness category Kronos has filed an S-1 with the SEC regarding a proposed secondary stock offering The company is preparing to manufacture its patented air purifiers in its U.S. factory to satisfy increasing demand Kronos will increase production of its 5-ply graphene mask, the only one of its kind made in the United States Kronos Advanced Technologies (OTC: KNOS) develops and sells a variety of disruptive, advanced, state-of-the-art air filtration and purification systems that…

Continue Reading

TuesdayFeb 08, 2022 1:16 pm

A Beachhead Market for Cepton: Every OEM Sees LiDAR as Necessity for Safer Driving

Cepton Technology is coming public this month via a merger with SPAC Growth Capital Acquisition Corp. Cepton is a leader in lidar technology, working with all the top automotive OEMs and signing the largest lidar contract to date where its MMT will be used in General Motors’ Ultra Cruise ADAS Cepton recently hosted a Virtual Investor Day where the management team provided comprehensive insight into the past and future as it targets $1.22 billion in revenue is 2026  Occasionally, an industry emerges that fundamentally changes the game. In the automobile industry, the future is autonomous driving, starting with Advanced Driver…

Continue Reading

TuesdayFeb 08, 2022 12:33 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotine The company has big plans for 2022, a year it expects to undertake three ground-breaking studies Lexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnerships The company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing fees and royalties For Lexaria Bioscience (NASDAQ: LEXX), a drug delivery company whose patented DehydraTECH(TM) technology has proven effective in improving bioavailability, speed of onset, and efficiency of orally-delivered fat-soluble active molecules…

Continue Reading

TuesdayFeb 08, 2022 11:56 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Marks a Major Step in Seamless Phase 2/3 Smoking Cessation Clinical Trial; Partners with Combat Stress to Treat PTSD among Veterans

Mydecine has summitted a pre-IND briefing package to the FDA in readiness for its phase 2/3 smoking cessation trial scheduled for Q2 2022 The study will be led by Dr. Matthew Johnson, with the placebo-controlled research being conducted at Johns Hopkins University Mydecine also announced its partnership with Combat Stress to use psilocybin in a psychoactive-assisted psychotherapy PTSD treatment program for veterans Combat Stress will also be one of several sites for the company’s upcoming clinical trials set to launch later in the year Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) plans to launch its seamless phase 2/3 smoking cessation…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered